These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 7747440)

  • 21. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
    Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells.
    Niedobitek G; Agathanggelou A; Herbst H; Whitehead L; Wright DH; Young LS
    J Pathol; 1997 Jun; 182(2):151-9. PubMed ID: 9274524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection.
    Iwata S; Wada K; Tobita S; Gotoh K; Ito Y; Demachi-Okamura A; Shimizu N; Nishiyama Y; Kimura H
    J Gen Virol; 2010 Jan; 91(Pt 1):42-50. PubMed ID: 19793909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latency of Epstein-Barr virus is stabilized by antisense-mediated control of the viral immediate-early gene BZLF-1.
    Prang N; Wolf H; Schwarzmann F
    J Med Virol; 1999 Dec; 59(4):512-9. PubMed ID: 10534735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of the Epstein-Barr virus ZEBRA protein's capacity to disrupt latency by the addition of heterologous activation regions.
    Baumann R; Warren G; Askovic S
    Virology; 1995 Aug; 211(1):64-72. PubMed ID: 7645237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
    Sugiura M; Imai S; Tokunaga M; Koizumi S; Uchizawa M; Okamoto K; Osato T
    Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
    Chiang AK; Tao Q; Srivastava G; Ho FC
    Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Latent and lytic Epstein-Barr virus gene expression in the peripheral blood of astronauts.
    Stowe RP; Kozlova EV; Sams CF; Pierson DL; Walling DM
    J Med Virol; 2011 Jun; 83(6):1071-7. PubMed ID: 21503923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemistry of latent Epstein-Barr virus infection and associated cell growth transformation.
    Kieff E; Hennessy K; Fennewald S; Matsuo T; Dambaugh T; Heller M; Hummel M
    IARC Sci Publ; 1985; (60):323-39. PubMed ID: 2998995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism.
    Furnari FB; Zacny V; Quinlivan EB; Kenney S; Pagano JS
    J Virol; 1994 Mar; 68(3):1827-36. PubMed ID: 8107245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
    Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
    J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase.
    Niedobitek G; Young LS; Lau R; Brooks L; Greenspan D; Greenspan JS; Rickinson AB
    J Gen Virol; 1991 Dec; 72 ( Pt 12)():3035-46. PubMed ID: 1662695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBV.
    Brousset P; Drouet E; Schlaifer D; Icart J; Payen C; Meggetto F; Marchou B; Massip P; Delsol G
    AIDS; 1994 May; 8(5):583-90. PubMed ID: 7914731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repression by RAZ of Epstein-Barr virus bZIP transcription factor EB1 is dimerization independent.
    Segouffin C; Gruffat H; Sergeant A
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1529-36. PubMed ID: 8757996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The molecular biology of Epstein-Barr virus.
    Ooka T
    Biomed Pharmacother; 1985; 39(2):59-66. PubMed ID: 2990591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2.
    Burgstahler R; Kempkes B; Steube K; Lipp M
    Biochem Biophys Res Commun; 1995 Oct; 215(2):737-43. PubMed ID: 7488016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Model of Epstein-Barr virus infection of human thymocytes: expression of viral genome and impact on cellular receptor expression in the T-lymphoblastic cell line, HPB-ALL.
    Paterson RL; Kelleher C; Amankonah TD; Streib JE; Xu JW; Jones JF; Gelfand EW
    Blood; 1995 Jan; 85(2):456-64. PubMed ID: 7811999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.
    Marquitz AR; Mathur A; Edwards RH; Raab-Traub N
    J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus infection and replication in a human epithelial cell system.
    Li QX; Young LS; Niedobitek G; Dawson CW; Birkenbach M; Wang F; Rickinson AB
    Nature; 1992 Mar; 356(6367):347-50. PubMed ID: 1312681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein.
    Nonkwelo C; Skinner J; Bell A; Rickinson A; Sample J
    J Virol; 1996 Jan; 70(1):623-7. PubMed ID: 8523583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.